Case Report

Extrahepatic Bile Duct Stricture and Elevated CA 19-9: Malignant or Benign?

Authors: Joshua Hyman, MD, Sharon P. Wilczynski, MD, Roderich E. Schwarz, MD

Abstract

Biliary obstruction due to a proximal bile duct stricture is commonly a result of cholangiocarcinoma. We describe a patient who began having intermittent episodes of jaundice 3 years after cholecystectomy. Despite endoscopic placement of a biliary stent and adequate biliary decompression, the serum CA 19-9 level remained elevated at 58 U/ml (normal <37 U/ml). Segmental bile duct resection and Roux-en-Y hepaticojejunostomy were done. The stricture was caused by a traumatic bile duct neuroma. Diagnostic and therapeutic considerations of this entity are discussed, with special emphasis on the value of noninvasive biliary imaging by magnetic resonance imaging (MRI), the utility and interpretation of the CA 19-9 level, and the role for resection or surgical biliary decompression.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg 1985; 72: 659–661.
 
2. Verbeek PC, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112: 866–871.
 
3. Rumalla A, Petersen BT. Diagnosis and therapy of biliary tract malignancy. Semin Gastrointest Dis 2000; 11: 168–173.
 
4. Zeff RH, Pfeffer RB, Adams PX, Ruoff M. Reoperation for amputation neuroma of the cystic duct. Am J Surg 1976; 131: 369–370.
 
5. Prinz RA, Greenlee HB, Caporale FS. Amputation neuroma of the cystic duct: A treatable cause of postcholecystectomy pain. Am Surg 1979; 45: 543–544.
 
6. Larson DM, Storsteen KA. Traumatic neuroma of the bile ducts with intrahepatic extension causing obstructive jaundice. Hum Pathol 1984; 15: 287–289.
 
7. Sugahara K, Yamamoto M, Iizuka H, Yoshioka M, Miura K. Spontaneous neuroma of the bile duct: A case report. Am J Gastroenterol 1985; 80: 807–809.
 
8. Rush BF Jr, Stefaniwsky AB, Sasso A, Dumitrescu I, Wexler D. Neuroma of the common bile duct. J Surg Oncol 1988; 39: 17–21.
 
9. Shumate CR, Curley SA, Cleary KR, Ames FC. Traumatic neuroma of the bile duct causing cholangitis and atrophy of the right hepatic lobe. South Med J 1992; 85: 425–427.
 
10. Nagata Y, Tomioka T, Chiba K, Kanematsu T. Traumatic neuroma of the common hepatic duct after laparoscopic cholecystectomy. Am J Gastroenterol 1995; 90: 1887–1888.
 
11. Pickens A, Vickers SM, Brown KL, Reddy VV, Thompson JA. An unusual etiology of biliary hilar obstruction and the potential role of acidic fibroblast growth factor in the development of a biliary neuroma. Am Surg 1999; 65: 47–51.
 
12. Koike N, Todoroki T, Kawamoto T, et al. Amputation neuroma mimics common hepatic duct carcinoma. Hepatogastroenterology 2000; 47: 639–643.
 
13. Knapen P, Ponette E, Marchal G, et al. Three cases of non-tumoural tight stenosis of the bifurcation of the hilar bile ducts. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1994; 161: 561–563.
 
14. Nakayama A, Imamura H, Shimada R, et al. Proximal bile duct stricture disguised as malignant neoplasm. Surgery 1999; 125: 514–521.
 
15. van Leeuwen DJ, Reeders JW. Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol 1999; 10 (Suppl 4): 89–93.
 
16. Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: Analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999; 94: 1941–1946.
 
17. Mann DV, Edwards R, Ho S, Lau WY, Glazer G. Elevated tumour marker CA19-9: Clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000; 26: 474–479.
 
18. Torok N, Gores GJ. Cholangiocarcinoma. Semin Gastrointest Dis 2001; 12: 125–132.
 
19. Bain VG, Abraham N, Jhangri GS, et al. Prospective study of biliary strictures to determine the predictors of malignancy. Can J Gastroenterol 2000; 14: 397–402.
 
20. Mendler MH, Bouillet P, Sautereau D, et al. Value of MR cholangiography in the diagnosis of obstructive diseases of the biliary tree: A study of 58 cases. Am J Gastroenterol 1998; 93: 2482–2490.
 
21. Blumgart LH, Kelley CJ, Benjamin IS. Benign bile duct stricture following cholecystectomy: Critical factors in management. Br J Surg 1984; 71: 836–843.
 
22. Blumgart LH, Kelley CJ. Hepaticojejunostomy in benign and malignant high bile duct stricture: Approaches to the left hepatic ducts. Br J Surg 1984; 71: 257–261.
 
23. Povoski SP, Karpeh M Jr, Conlon KC, et al. Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg 1999; 3: 496–505.